trial

Auditory Control Enhancement (ACE) in Schizophrenia

NCTId NCT06155695
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Terminated
Enrollment 12 (actual)
Sponsored by Brian A Coffman, PhD
Primary completion 2024-12-18
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Terminated
Enrollment
12 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2023-09-05
Primary completion
2024-12-18
Eligibility
ALL · 18 Years · 40 Years

Interventions & indications

Drugs
transcranial direct current stimulation (tDCS)

Sponsors

Brian A Coffman, PhDLead Sponsor
National Institute of Mental Health (NIMH)Collaborator

Investigators

1
Brian A Coffman, PhDPrincipal Investigator

Sites

1 total
Pittsburgh, United States

Facts & assertions

4 sourced
Enrollment
12
Phase
NA
Primary Completion Date
2024-12-18
Status
TERMINATED
relationships
The graph out of here
drug
transcranial direct current stimulation (tDCS)
drug
lead_sponsor
Brian A Coffman, PhD
company
collaborator
National Institute of Mental Health (NIMH)
company
indication
Hallucinations
indication
Auditory Hallucinations
indication
investigator
Brian A Coffman, PhD
person